The bovine pineal gland contains delta and mu but not kappa or ORL1 opioid receptor subtypes
Govitrapong, P.; Sawlom, S.; Chetsawang, B.; Sangchot, P.; Ebadi, M.
Proceedings of the Western Pharmacology Society 45: 32-35
2002
ISSN/ISBN: 0083-8969 PMID: 12434519 Document Number: 551090
Document emailed within 1 workday
Related Documents
Sofuoglu, M.; Portoghese, P.S.; Takemori, A.E. 1991: Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes Journal of Pharmacology and Experimental Therapeutics 257(2): 676-680Jiang, Q.; Takemori, A.E.; Sultana, M.; Portoghese, P.S.; Bowen, W.D.; Mosberg, H.I.; Porreca, F. 1991: Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes Journal of Pharmacology and Experimental Therapeutics 257(3): 1069-1075
Aloyo, V.J. 1992: Identification and characterization of delta opioid binding sites in the bovine pineal Journal of Pharmacology and Experimental Therapeutics 262(1): 292-297
Fang, L.; Knapp, R.J.; Horvath, R.; Matsunaga, T.O.; Haaseth, R.C.; Hruby, V.J.; Porreca, F.; Yamamura, H.I. 1994: Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity Journal of Pharmacology and Experimental Therapeutics 268(2): 836-846
Mosberg, H.I.; Heyl, D.L.; Haaseth, R.C.; Omnaas, J.R.; Medzihradsky, F.; Smith, C.B. 1990: Cyclic dermorphin-like tetrapeptides with delta-opioid receptor selectivity. 3. Effect of residue 3 modification on in vitro opioid activity Molecular Pharmacology 38(6): 924-928
Schoffelmeer, A.N.; Yao, Y.H.; Gioannini, T.L.; Hiller, J.M.; Ofri, D.; Roques, B.P.; Simon, E.J. 1990: Cross-linking of human [125I]beta-endorphin to opioid receptors in rat striatal membranes: biochemical evidence for the existence of a mu/delta opioid receptor complex Journal of Pharmacology and Experimental Therapeutics 253(1): 419-426
Kamei, J.; Iwamoto, Y.; Misawa, M.; Nagase, H.; Kasuya, Y. 1994: Antitussive effect of (+/-) pentazocine in diabetic mice is mediated by delta-sites, but not by mu- or kappa-opioid receptors Nihon Shinkei Seishin Yakurigaku Zasshi 14(3): 147-152
Negus, S.S.; Henriksen, S.J.; Mattox, A.; Pasternak, G.W.; Portoghese, P.S.; Takemori, A.E.; Weinger, M.B.; Koob, G.F. 1993: Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats Journal of Pharmacology and Experimental Therapeutics 265(3): 1245-1252
Guirimand, F.; Strimbu-Gozariu, M.; Willer, J.C.; Le Bars, D. 1994: Effects of mu, delta and kappa opioid antagonists on the depression of a C-fiber reflex by intrathecal morphine and DAGO in the rat Journal of Pharmacology and Experimental Therapeutics 269(3): 1007-1020
Jin, W.; Terman, G.W.; Chavkin, C. 1997: Kappa opioid receptor tolerance in the guinea pig hippocampus Journal of Pharmacology and Experimental Therapeutics 281(1): 123-128
Illes, P.; Pfeiffer, N.; von Kügelgen, I.; Starke, K. 1985: Presynaptic opioid receptor subtypes in the rabbit ear artery Journal of Pharmacology and Experimental Therapeutics 232(2): 526-533
Belcheva, M.M.; Barg, J.; McHale, R.J.; Dawn, S.; Ho, M.T.; Ignatova, E.; Coscia, C.J. 1993: Differential down- and up-regulation of rat brain opioid receptor types and subtypes by buprenorphine Molecular Pharmacology 44(1): 173-179
Pan, Y.X.; Cheng, J.; Xu, J.; Rossi, G.; Jacobson, E.; Ryan-Moro, J.; Brooks, A.I.; Dean, G.E.; Standifer, K.M.; Pasternak, G.W. 1995: Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor Molecular Pharmacology 47(6): 1180-1188
Arakawa, K.; Akami, T.; Okamoto, M.; Akioka, K.; Nakai, I.; Oka, T.; Nagase, H. 1993: Immunosuppression by delta opioid receptor antagonist Transplantation Proceedings 25(1 Part 1): 738-740
Rónai, A.Z.; Botyánszki, J.; Magyar, A.; Borsodi, A.; Benyhe, S.; Medzihradszky, K. 1993: Novel, delta-opioid receptor-selective peptide antagonists: demonstration of a possible opioid interaction in the absence of a protonated nitrogen and attempts to locate the protonated nitrogen site Archives Internationales de Pharmacodynamie et de Therapie 323: 114-125
Garzón, J.; Sánchez-Blázquez, P.; Lee, N.M. 1984: 3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type Journal of Pharmacology and Experimental Therapeutics 231(1): 33-37
Hall, E.D.; Wolf, D.L.; McCall, R.B. 1988: Cardiovascular depressant effects of the kappa opioid receptor agonists U50488H and spiradoline mesylate Circulatory Shock 26(4): 409-417
Portoghese, P.S. 1993: The design of delta-selective opioid receptor antagonists Farmaco 48(2): 243-251
Ward, S.J.; Takemori, A.E. 1983: Relative involvement of receptor subtypes in opioid-induced inhibition of gastrointestinal transit in mice Journal of Pharmacology and Experimental Therapeutics 224(2): 359-363
Pei, G.; Kieffer, B.L.; Lefkowitz, R.J.; Freedman, N.J. 1995: Agonist-dependent phosphorylation of the mouse delta-opioid receptor: involvement of G protein-coupled receptor kinases but not protein kinase C Molecular Pharmacology 48(2): 173-177